• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒 2 感染对多发性硬化症中神经退行性变发展的影响。

The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis.

机构信息

Department of General Biochemistry, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland.

Department of Neurological Rehabilitation, Medical University of Lodz, Milionowa 14, 93-113 Lodz, Poland.

出版信息

Int J Mol Sci. 2021 Feb 11;22(4):1804. doi: 10.3390/ijms22041804.

DOI:10.3390/ijms22041804
PMID:33670394
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7918534/
Abstract

The novel coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remains a global challenge. Currently, there is some information on the consequences of COVID-19 infection in multiple sclerosis (MS) patients, as it is a newly discovered coronavirus, but its far-reaching effects on participation in neurodegenerative diseases seem to be significant. Recent cases reports showed that SARS-CoV-2 may be responsible for initiating the demyelination process in people who previously had no symptoms associated with any nervous system disorders. It is presently known that infection of SARS-CoV-2 evokes cytokine storm syndrome, which may be one of the factors leading to the acute cerebrovascular disease. One of the substantial problems is the coexistence of cerebrovascular disease and MS in an individual's life span. Epidemiological studies showed an enhanced risk of death rate from vascular disabilities in MS patients of approximately 30%. It has been demonstrated that patients with severe SARS-CoV-2 infection usually show increased levels of D-dimer, fibrinogen, C-reactive protein (CRP), and overactivation of blood platelets, which are essential elements of prothrombotic events. In this review, the latest knowledge gathered during an ongoing pandemic of SARS-CoV-2 infection on the neurodegeneration processes in MS is discussed.

摘要

新型冠状病毒病 2019(COVID-19)大流行是由严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)引起的,仍然是一个全球性的挑战。目前,关于 COVID-19 感染对多发性硬化症(MS)患者的影响有一些信息,因为这是一种新发现的冠状病毒,但它对参与神经退行性疾病的深远影响似乎是重大的。最近的病例报告表明,SARS-CoV-2 可能负责引发先前与任何神经系统疾病无关的症状的人发生脱髓鞘过程。目前已知,SARS-CoV-2 的感染会引发细胞因子风暴综合征,这可能是导致急性脑血管病的因素之一。一个实质性的问题是脑血管病和 MS 在个体的寿命中同时存在。流行病学研究表明,MS 患者死于血管性残疾的风险增加约 30%。已经证明,患有严重 SARS-CoV-2 感染的患者通常表现出 D-二聚体、纤维蛋白原、C 反应蛋白(CRP)和血小板过度活化水平升高,这些都是血栓前事件的重要因素。在这篇综述中,讨论了在 SARS-CoV-2 感染持续大流行期间,关于 MS 中神经退行性过程的最新知识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0d7/7918534/0960555154fd/ijms-22-01804-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0d7/7918534/a466f80c403d/ijms-22-01804-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0d7/7918534/0960555154fd/ijms-22-01804-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0d7/7918534/a466f80c403d/ijms-22-01804-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0d7/7918534/0960555154fd/ijms-22-01804-g002.jpg

相似文献

1
The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis.严重急性呼吸综合征冠状病毒 2 感染对多发性硬化症中神经退行性变发展的影响。
Int J Mol Sci. 2021 Feb 11;22(4):1804. doi: 10.3390/ijms22041804.
2
The Potential Role of COVID-19 in the Pathogenesis of Multiple Sclerosis-A Preliminary Report.COVID-19 在多发性硬化症发病机制中的潜在作用——初步报告。
Viruses. 2021 Oct 17;13(10):2091. doi: 10.3390/v13102091.
3
Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy.COVID-19 中的细胞因子风暴:从病毒感染到免疫反应、诊断和治疗。
Int J Biol Sci. 2022 Jan 1;18(2):459-472. doi: 10.7150/ijbs.59272. eCollection 2022.
4
Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic?新型冠状病毒2型感染对神经退行性疾病和神经精神疾病的影响:一场延迟的大流行?
Neurologia (Engl Ed). 2020 May;35(4):245-251. doi: 10.1016/j.nrl.2020.04.002. Epub 2020 Apr 17.
5
Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.托珠单抗治疗细胞因子风暴综合征的 SARS-CoV-2 患者:一项叙述性综述。
Rev Recent Clin Trials. 2021;16(2):138-145. doi: 10.2174/1574887115666200917110954.
6
An enlightening role for cytokine storm in coronavirus infection.细胞因子风暴在冠状病毒感染中的启示作用。
Clin Immunol. 2021 Jan;222:108615. doi: 10.1016/j.clim.2020.108615. Epub 2020 Oct 23.
7
Respiratory issues in patients with multiple sclerosis as a risk factor during SARS-CoV-2 infection: a potential role for exercise.多发性硬化症患者在感染 SARS-CoV-2 期间的呼吸问题:运动的潜在作用。
Mol Cell Biochem. 2023 Jul;478(7):1533-1559. doi: 10.1007/s11010-022-04610-1. Epub 2022 Nov 21.
8
SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients.SARS-CoV-2 引起的细胞因子反应与其他严重感染患者中导致细胞因子风暴的呼吸道病毒不同。
Front Immunol. 2021 Mar 1;12:629193. doi: 10.3389/fimmu.2021.629193. eCollection 2021.
9
The effects of novel coronavirus (SARS-CoV-2) infection on cardiovascular diseases and cardiopulmonary injuries.新型冠状病毒(SARS-CoV-2)感染对心血管疾病和心肺损伤的影响。
Stem Cell Res. 2021 Mar;51:102168. doi: 10.1016/j.scr.2021.102168. Epub 2021 Jan 12.
10
Cytokine storm induced by SARS-CoV-2 infection: The spectrum of its neurological manifestations.新型冠状病毒感染引起的细胞因子风暴:其神经系统表现谱。
Cytokine. 2021 Feb;138:155404. doi: 10.1016/j.cyto.2020.155404. Epub 2020 Dec 11.

引用本文的文献

1
Multiple Sclerosis and COVID-19: An Overview on Risk, Severity, and Association With Disease Modifying Therapies.多发性硬化症与2019冠状病毒病:关于风险、严重程度以及与疾病修正治疗关联的概述
Neurosci Insights. 2024 Sep 24;19:26331055241265668. doi: 10.1177/26331055241265668. eCollection 2024.
2
The Evolvement of OCT and OCT-A in Identifying Multiple Sclerosis Biomarkers.光学相干断层扫描(OCT)及光学相干断层扫描血管造影(OCT-A)在识别多发性硬化生物标志物方面的进展
Biomedicines. 2023 Nov 11;11(11):3031. doi: 10.3390/biomedicines11113031.
3
The association of upper respiratory infections with neuro-radiological course and attack rate of multiple sclerosis: Results from a large prospective cohort.

本文引用的文献

1
Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients.致病性T细胞和炎性单核细胞在重症COVID-19患者中引发炎症风暴。
Natl Sci Rev. 2020 Jun;7(6):998-1002. doi: 10.1093/nsr/nwaa041. Epub 2020 Mar 13.
2
A cross-sectional study of olfactory and taste disorders among COVID-19 patients in China.中国 COVID-19 患者嗅觉和味觉障碍的横断面研究。
Mil Med Res. 2021 Sep 13;8(1):51. doi: 10.1186/s40779-021-00339-y.
3
Demyelinating Changes Alike to Multiple Sclerosis: A Case Report of Rare Manifestations of COVID-19.
上呼吸道感染与多发性硬化症的神经放射学病程及发作率之间的关联:一项大型前瞻性队列研究的结果
Mult Scler J Exp Transl Clin. 2023 Sep 25;9(3):20552173231196992. doi: 10.1177/20552173231196992. eCollection 2023 Jul-Sep.
4
The Effects of SARS-CoV-2 Infection on the Cognitive Functioning of Patients with Pre-Existing Dementia.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染对已患痴呆症患者认知功能的影响
J Alzheimers Dis Rep. 2023 Feb 14;7(1):119-128. doi: 10.3233/ADR-220090. eCollection 2023.
5
COVID-19 and its implications on the clinico-radiological course of multiple sclerosis: A case-control study.新型冠状病毒肺炎及其对多发性硬化症临床放射学病程的影响:一项病例对照研究。
Med Clin (Engl Ed). 2023 Mar 10;160(5):187-192. doi: 10.1016/j.medcle.2022.06.021. Epub 2023 Mar 3.
6
T cell responses to COVID-19 infection and vaccination in patients with multiple sclerosis receiving disease-modifying therapy.多发性硬化症患者在接受疾病修正治疗时对 COVID-19 感染和疫苗接种的 T 细胞反应。
Mult Scler. 2023 May;29(6):648-656. doi: 10.1177/13524585221134216. Epub 2022 Nov 28.
7
Survival and Neurogenesis-Promoting Effects of the Co-Overexpression of and Genes on Wharton's Jelly-Derived Mesenchymal Stem Cells.基因和基因共过表达对沃顿胶间充质干细胞的存活及促进神经发生作用
Life (Basel). 2022 Sep 9;12(9):1406. doi: 10.3390/life12091406.
8
COVID-19 and its implications on the clinico-radiological course of multiple sclerosis: A case-control study.新型冠状病毒肺炎及其对多发性硬化临床-放射学病程的影响:一项病例对照研究。
Med Clin (Barc). 2023 Mar 10;160(5):187-192. doi: 10.1016/j.medcli.2022.06.020. Epub 2022 Aug 10.
9
Self-Assembled Nanoscale Materials for Neuronal Regeneration: A Focus on BDNF Protein and Nucleic Acid Biotherapeutic Delivery.用于神经元再生的自组装纳米材料:聚焦脑源性神经营养因子蛋白和核酸生物治疗递送
Nanomaterials (Basel). 2022 Jun 30;12(13):2267. doi: 10.3390/nano12132267.
10
K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research.K18- 和 CAG-hACE2 转基因小鼠模型与 SARS-CoV-2:对神经退行性变研究的启示。
Molecules. 2022 Jun 28;27(13):4142. doi: 10.3390/molecules27134142.
类似多发性硬化症的脱髓鞘改变:1例COVID-19罕见表现的病例报告
Case Rep Neurol Med. 2020 Dec 28;2020:6682251. doi: 10.1155/2020/6682251. eCollection 2020.
4
The 2020 race towards SARS-CoV-2 specific vaccines.2020 年抗击 SARS-CoV-2 特异性疫苗竞赛。
Theranostics. 2021 Jan 1;11(4):1690-1702. doi: 10.7150/thno.53691. eCollection 2021.
5
SARS-CoV-2, multiple sclerosis, and focal deficit in a postpartum woman: A case report.一名产后女性感染严重急性呼吸综合征冠状病毒2、患多发性硬化症并出现局灶性神经功能缺损:病例报告
Exp Ther Med. 2021 Jan;21(1):92. doi: 10.3892/etm.2020.9524. Epub 2020 Nov 26.
6
The S1 protein of SARS-CoV-2 crosses the blood-brain barrier in mice.SARS-CoV-2 的 S1 蛋白可穿越血脑屏障进入小鼠脑内。
Nat Neurosci. 2021 Mar;24(3):368-378. doi: 10.1038/s41593-020-00771-8. Epub 2020 Dec 16.
7
A first presentation of multiple sclerosis with concurrent COVID-19 infection.首例同时患有新型冠状病毒肺炎感染的多发性硬化症病例
eNeurologicalSci. 2021 Mar;22:100299. doi: 10.1016/j.ensci.2020.100299. Epub 2020 Dec 4.
8
Role of testosterone in COVID-19 patients - A double-edged sword?睾酮在 COVID-19 患者中的作用——一把双刃剑?
Med Hypotheses. 2020 Nov;144:110287. doi: 10.1016/j.mehy.2020.110287. Epub 2020 Sep 17.
9
Revisiting the Pathoetiology of Multiple Sclerosis: Has the Tail Been Wagging the Mouse?重新审视多发性硬化症的发病机制:是尾巴在摇狗吗?
Front Immunol. 2020 Sep 29;11:572186. doi: 10.3389/fimmu.2020.572186. eCollection 2020.
10
COVID-19-Associated Coagulopathy and Inflammatory Response: What Do We Know Already and What Are the Knowledge Gaps?COVID-19 相关凝血功能障碍与炎症反应:我们已经了解了什么,还有哪些知识空白?
Anesth Analg. 2020 Nov;131(5):1324-1333. doi: 10.1213/ANE.0000000000005147.